All these years (a century in fact) the doctors all over the world have tested our blood pressure inaccurately; consequently denying us proper treatment. I hope they do something about it and SOON. Now the story from today’s Independent (24 August 2011):

Blood pressure testers
Not fit for purpose

By Jeremy Laurance, Health Editor

UP TO one-quarter of the six million people being treated for high blood pressure in the UK may have been misdiagnosed.

The standard method of measuring blood pressure is inaccurate and should be replaced by 24-hour monitoring using a device worn on the waist, experts advise. The recommendation by a panel of the National Institute of Clinical Excellence (Nice), is expected to be adopted around the world – the first change to the way blood pressure is measured for more than a century.

High blood pressure affects an estimated 12 million people in UK, one in four of the adult population and one in two of those over 60. But it remains undiagnosed in more than half of them. It is one of the most important causes of heart disease, strokes and kidney disease and controlling it is one of the most effective ways of preventing premature death.

Traditionally blood pressure is taken by a cuff attached to the patient’s upper arm and pumped up to block flow before being released slowly to measure the pressure at which the blood starts to flow again.

Many patients suffer from “white coat syndrome” – their blood pressure rises because of anxiety triggered by a visit to the surgery. A more accurate measure can be obtained by monitoring blood pressure for 24 hours by using a device attached to the waist that pumps up the cuff worn around the arm every half hour and takes a reading, all of which are then averaged out.

Fewer than one in 10 patients are diagnosed in this way. The devices cost more than £1,000 and drugs prescribed for blood pressure on the NHS cost £1bn a year. Nice estimates that introducing the devices would save £10bn annually after five years.

Bryan Williams, Professor of Medicine at the University of Leicester, who led the Nice panel, said:”The important recommendation in this guideline will affect the treatment of millions of people in our country. It is a step change that is likely to be replicated across the world




_______________________________________________
assam mailing list
assam@assamnet.org
http://assamnet.org/mailman/listinfo/assam_assamnet.org

Reply via email to